Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Enalapril

Known as: Enalaprila, Enalaprilum, (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline 
A dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, enalapril is… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Background—Elevated renin-angiotensin-aldosterone system activity correlates with left ventricular hypertrophy (LVH) and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Background—Combined inhibition of the angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) may produce greater… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND It has recently been reported that the use of calcium-channel blockers for hypertension may be associated with an… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND It is not known whether the treatment of patients with asymptomatic left ventricular dysfunction reduces mortality and… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Long-term administration of angiotensin-converting--enzyme (ACE) inhibitors has been shown to improve survival in… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
BACKGROUND Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
BACKGROUND To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
To evaluate the influence of the angiotensin-converting enzyme inhibitor, enalapril (2.5 to 40 mg/day), on the prognosis of… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
  • The New England journal of medicine
  • 1987
  • Corpus ID: 27190749
To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of… Expand
Is this relevant?